Company / CapEx per Share
Dexcom CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.94
FY2025
5-year range
$0.51 / $4.05
FY2021-FY2025
Trend
+2.9%
vs FY2024
Sector context
#65 of 148
Health Care
What the data says
At $0.94, Dexcom's capex per share ranks #65 of 148 in the Health Care sector. CapEx per Share has increased for 3 consecutive years, from $0.51 in FY2022 to $0.94 in FY2025.
Based on SEC 10-K filings.
0.94 in FY2025 with a 5-year CAGR of -14.5%.
Improved from $0.61 to $0.94 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +22.6%
- 5-Year CAGR
- -14.5%
- 10-Year CAGR
- -
Sector benchmark
#65 of 148 in Health CareTop 44% of 148This company $0.94 Sector average $1.67
▼
-43.5% below sector average
Key checks
Key Insights
- Dexcom's capex per share has grown for 3 consecutive years.
- In FY2025, capex per share increased 2.9% year-over-year.
- Ranks #65 out of 148 companies in the Health Care sector.
- Peak capex per share was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 26.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.94 | +2.9% |
| FY2024 | $0.92 | +49.6% |
| FY2023 | $0.61 | +19.7% |
| FY2022 | $0.51 | -87.3% |
| FY2021 | $4.05 | +95.6% |
| FY2020 | $2.07 | +5.4% |
| FY2019 | $1.97 | +154.8% |
| FY2018 | $0.77 | +95.9% |
| FY2017 | $0.39 | +98.5% |
| FY2016 | $0.20 | +94.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026